US5188826A
(en)
*
|
1988-02-08 |
1993-02-23 |
Insite Vision Incorporated |
Topical ophthalmic suspensions
|
US5521222A
(en)
*
|
1989-09-28 |
1996-05-28 |
Alcon Laboratories, Inc. |
Topical ophthalmic pharmaceutical vehicles
|
US5461081A
(en)
*
|
1989-09-28 |
1995-10-24 |
Alcon Laboratories, Inc. |
Topical ophthalmic pharmaceutical vehicles
|
US5252318A
(en)
*
|
1990-06-15 |
1993-10-12 |
Allergan, Inc. |
Reversible gelation compositions and methods of use
|
US5460834A
(en)
*
|
1991-12-13 |
1995-10-24 |
Alcon Laboratories, Inc. |
Combinations of polymers for use in physiological tear compositions
|
EP0551626A1
(en)
*
|
1991-12-19 |
1993-07-21 |
LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. |
Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
|
WO1993017664A1
(en)
*
|
1992-03-02 |
1993-09-16 |
Alcon Laboratories, Inc. |
Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
|
SE512871C2
(sv)
*
|
1992-08-20 |
2000-05-29 |
Santen Oy |
Oftalmologisk beredning innehållande pilokarpin och ytterligare medel för behandling av okular hypertension
|
DK0661045T3
(da)
*
|
1992-09-18 |
2002-10-28 |
Yamanouchi Pharma Co Ltd |
Hydrogelpræparat med forsinket frigivelse
|
ES2141775T3
(es)
*
|
1993-04-16 |
2000-04-01 |
Wakamoto Pharma Co Ltd |
Composicion medicinal a base de agua termicamente gelificante reversible.
|
WO1995000143A1
(en)
*
|
1993-06-24 |
1995-01-05 |
Leiras Oy |
Composition for ophthalmic use
|
AU7668894A
(en)
*
|
1993-08-13 |
1995-03-14 |
Vitaphore Corporation |
Hydrogel-based microsphere drug delivery systems
|
KR950007873A
(ko)
*
|
1993-09-20 |
1995-04-15 |
후꾸하라 요시하루 |
생리 활성 물질 지속 방출형의 의약 제제
|
US5458879A
(en)
*
|
1994-03-03 |
1995-10-17 |
The Procter & Gamble Company |
Oral vehicle compositions
|
WO1995024430A2
(en)
|
1994-03-04 |
1995-09-14 |
University Of Washington |
Block and graft copolymers and methods relating thereto
|
SE9401109D0
(sv)
*
|
1994-03-31 |
1994-03-31 |
Leiras Oy |
Opthalmic composition II
|
SE9401108D0
(sv)
*
|
1994-03-31 |
1994-03-31 |
Leiras Oy |
Ophthalmic composition I
|
US5585398A
(en)
*
|
1994-07-15 |
1996-12-17 |
Ernst; Amy A. |
Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use
|
US5840338A
(en)
*
|
1994-07-18 |
1998-11-24 |
Roos; Eric J. |
Loading of biologically active solutes into polymer gels
|
US5603955A
(en)
*
|
1994-07-18 |
1997-02-18 |
University Of Cincinnati |
Enhanced loading of solutes into polymer gels
|
GB9415290D0
(en)
|
1994-07-28 |
1994-09-21 |
Zeneca Ltd |
Gel formation
|
US5599534A
(en)
*
|
1994-08-09 |
1997-02-04 |
University Of Nebraska |
Reversible gel-forming composition for sustained delivery of bio-affecting substances, and method of use
|
US5827835A
(en)
*
|
1994-08-30 |
1998-10-27 |
Alcon Laboratories, Inc. |
Thermally-gelling emulsions
|
WO1996006597A1
(en)
*
|
1994-08-30 |
1996-03-07 |
Alcon Laboratories, Inc. |
Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers
|
US5516808A
(en)
*
|
1994-10-27 |
1996-05-14 |
Sawaya; Assad S. |
Topical cellulose pharmaceutical formulation
|
US5985383A
(en)
*
|
1995-03-15 |
1999-11-16 |
Acushnet Company |
Conforming shoe construction and gel compositions therefor
|
US5955159A
(en)
*
|
1995-03-15 |
1999-09-21 |
Acushnet Company |
Conforming shoe construction using gels and method of making the same
|
US5939485A
(en)
*
|
1995-06-19 |
1999-08-17 |
Medlogic Global Corporation |
Responsive polymer networks and methods of their use
|
US5939157A
(en)
*
|
1995-10-30 |
1999-08-17 |
Acushnet Company |
Conforming shoe construction using gels and method of making the same
|
DE19511322C2
(de)
*
|
1995-03-28 |
1999-09-02 |
Mann Gerhard Chem Pharm Fab |
Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
|
CA2230727A1
(en)
*
|
1995-06-16 |
1997-01-03 |
Medlogic Global Corporation |
Responsive polymer networks and methods of their use
|
JP3766707B2
(ja)
*
|
1995-10-25 |
2006-04-19 |
ディップソール株式会社 |
亜鉛及び亜鉛合金の撥水処理用水溶性組成物及び撥水処理方法
|
US5766704A
(en)
*
|
1995-10-27 |
1998-06-16 |
Acushnet Company |
Conforming shoe construction and gel compositions therefor
|
US6610292B2
(en)
*
|
1995-11-22 |
2003-08-26 |
Ista Pharmaceuticals, Inc. |
Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
|
US5866120A
(en)
|
1995-11-22 |
1999-02-02 |
Advanced Corneal Systems, Inc. |
Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
|
WO1997020578A1
(en)
*
|
1995-12-04 |
1997-06-12 |
University Of Miami |
Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
|
US5723131A
(en)
*
|
1995-12-28 |
1998-03-03 |
Johnson & Johnson Vision Products, Inc. |
Contact lens containing a leachable absorbed material
|
US6280745B1
(en)
|
1997-12-23 |
2001-08-28 |
Alliance Pharmaceutical Corp. |
Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
EP0920338A2
(en)
*
|
1996-08-12 |
1999-06-09 |
MedLogic Global Corporation |
Composition for pharmaceutical applications
|
US5888493A
(en)
*
|
1996-12-05 |
1999-03-30 |
Sawaya; Assad S. |
Ophthalmic aqueous gel formulation and related methods
|
AU5906898A
(en)
*
|
1997-01-02 |
1998-07-31 |
Medlogic Global Corporation |
Responsive polymer networks and methods of their use
|
WO1998032433A1
(en)
*
|
1997-01-24 |
1998-07-30 |
Medlogic Global Corporation |
Conformable structures
|
WO1998055147A2
(en)
*
|
1997-06-06 |
1998-12-10 |
Battelle Memorial Institute |
Reversible geling co-polymer and method of making
|
GB9718568D0
(en)
|
1997-09-03 |
1997-11-05 |
Chauvin Pharmaceuticals Limite |
Compositions
|
US20040063678A1
(en)
*
|
1997-10-06 |
2004-04-01 |
Bausch & Lomb Incorporated |
Dexamethasone Gel
|
DE19744113A1
(de)
*
|
1997-10-06 |
1999-04-15 |
Mann Gerhard Chem Pharm Fab |
Dexamethason-Gel
|
US6417247B1
(en)
*
|
1997-10-14 |
2002-07-09 |
Beth L. Armstrong |
Polymer/ceramic composites
|
AU753206B2
(en)
*
|
1997-12-23 |
2002-10-10 |
Alliance Pharmaceutical Corporation |
Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
|
US20040228794A1
(en)
*
|
1998-04-10 |
2004-11-18 |
Battelle Memorial Institute |
Therapeutic agent carrier compositions
|
US6159483A
(en)
*
|
1998-06-01 |
2000-12-12 |
Colgate-Palmolive Company |
Stabilized liquid aqueous composition
|
US5968480A
(en)
*
|
1998-07-09 |
1999-10-19 |
Colgate Palmolive Company |
Oral composition exhibiting enhanced antiplaque efficacy
|
US6337130B1
(en)
|
1998-07-30 |
2002-01-08 |
Zeneca Limited |
Acid-triggered release microcapsules
|
EP1109563A4
(en)
|
1998-08-04 |
2009-07-22 |
Madash Llp |
HEAT-SENSITIVE HYDROGELS WITH MODIFIED TERMINATION
|
CN1169573C
(zh)
*
|
1998-09-28 |
2004-10-06 |
参天制药株式会社 |
用于治疗角结膜障碍的、包含作为活性组分的钠尿肽的泪液分泌促进剂或滴眼剂
|
US6312666B1
(en)
|
1998-11-12 |
2001-11-06 |
3M Innovative Properties Company |
Methods of whitening teeth
|
US6312667B1
(en)
|
1998-11-12 |
2001-11-06 |
3M Innovative Properties Company |
Methods of etching hard tissue in the oral environment
|
US6669927B2
(en)
|
1998-11-12 |
2003-12-30 |
3M Innovative Properties Company |
Dental compositions
|
US6245740B1
(en)
*
|
1998-12-23 |
2001-06-12 |
Amgen Inc. |
Polyol:oil suspensions for the sustained release of proteins
|
US6451346B1
(en)
*
|
1998-12-23 |
2002-09-17 |
Amgen Inc |
Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
|
EP1185309B1
(en)
*
|
1999-06-11 |
2006-10-04 |
Cytyc Corporation |
Liquid gel composition for mapping a breast milk duct prior to surgical excision of the duct or other breast tissue
|
US6521431B1
(en)
*
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
US20040037891A1
(en)
*
|
1999-10-04 |
2004-02-26 |
Karagoezian Hampar L. |
Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
|
US20040033260A1
(en)
*
|
1999-10-19 |
2004-02-19 |
The Procter & Gamble Company |
Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
|
US20040234457A1
(en)
*
|
1999-10-19 |
2004-11-25 |
The Procter & Gamble Company |
Methods of preventing and treating SARS using low pH respiratory tract compositions
|
WO2001041735A2
(en)
*
|
1999-12-07 |
2001-06-14 |
Amgen Inc. |
Thermosensitive biodegradable hydrogels based on low molecular weight pluronics
|
FR2802097B1
(fr)
*
|
1999-12-14 |
2002-12-13 |
Invest S Therapeutiques Essais |
Composition sous forme de gel prevue pour recevoir un principe actif en solution ou en suspension, notamment pour application sur une muqueuse et procede de fabrication
|
TWI227143B
(en)
|
1999-12-15 |
2005-02-01 |
Guo-Jiun Sung |
In situ gel formation for ophthalmic delivery by combining Pluronic/Carbopol medic composition and its preparing method
|
US6660247B1
(en)
|
2000-06-23 |
2003-12-09 |
Battelle Memorial Institute |
Multiple stimulus reversible hydrogels
|
US6303290B1
(en)
|
2000-09-13 |
2001-10-16 |
The Trustees Of The University Of Pennsylvania |
Encapsulation of biomaterials in porous glass-like matrices prepared via an aqueous colloidal sol-gel process
|
US7803392B2
(en)
*
|
2000-12-27 |
2010-09-28 |
University Of Kentucky Research Foundation |
pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
|
US20040076682A1
(en)
*
|
2001-02-15 |
2004-04-22 |
Toshiyuki Kohzaki |
Novel ophthalmic compositions
|
AU2002306795A1
(en)
*
|
2001-03-21 |
2002-10-08 |
Madash Llc |
Thermally reversible water in oil in water emulsions
|
JP2003089752A
(ja)
*
|
2001-03-23 |
2003-03-28 |
Canon Inc |
刺激応答性ポリマーを含む組成物、それを含むインク組成物、並びに該インク組成物を用いた画像形成方法および装置
|
FR2823439A1
(fr)
*
|
2001-04-13 |
2002-10-18 |
Oreal |
Composition de bain gelifiantes, relaxantes
|
DE10132876A1
(de)
*
|
2001-07-06 |
2003-01-30 |
Medproject Pharma Entwicklungs |
Zweiphasige, tropfbare Hydrogele zur Anwendung am Auge
|
US20080063620A1
(en)
*
|
2001-08-13 |
2008-03-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Novel reverse thermo-sensitive block copolymers
|
US20030082235A1
(en)
*
|
2001-08-13 |
2003-05-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Novel reverse thermo-sensitive block copolymers
|
US6620405B2
(en)
|
2001-11-01 |
2003-09-16 |
3M Innovative Properties Company |
Delivery of hydrogel compositions as a fine mist
|
US20070196415A1
(en)
*
|
2002-11-14 |
2007-08-23 |
Guohua Chen |
Depot compositions with multiple drug release rate controls and uses thereof
|
EP1446101B1
(en)
|
2001-11-14 |
2011-03-23 |
Durect Corporation |
Catheter injectable depot compositions and uses thereof
|
BR0206984A
(pt)
*
|
2001-11-14 |
2004-02-03 |
Alza Corp |
Composições de depósito injetáveis e uso destas
|
US7204997B2
(en)
*
|
2002-01-29 |
2007-04-17 |
Supratek Pharma Inc. |
Responsive microgel and methods related thereto
|
WO2003080119A1
(en)
*
|
2002-03-26 |
2003-10-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Responsive biomedical composites
|
US20030204180A1
(en)
*
|
2002-04-30 |
2003-10-30 |
Kimberly-Clark Worldwide, Inc. |
Temperature responsive delivery systems
|
EP1878447A3
(en)
*
|
2002-05-09 |
2008-12-31 |
Ultrast LLC |
Medium for contrast enhancement or convenience for ultrasonic, endoscopic and other medical examinations
|
AU2003239850B2
(en)
*
|
2002-05-09 |
2008-08-28 |
Ultrast Llc |
Medium for contrast enhancement use for ultrasonic, endoscopic and other medical examinations
|
DE10224352A1
(de)
*
|
2002-06-01 |
2003-12-11 |
Mueller Schulte Detlef |
Thermosensitive Polymerträger mit veränderbarer physikalischer Struktur für die biochemische Analytik, Diagnostik und Therapie
|
JP3891571B2
(ja)
*
|
2002-06-14 |
2007-03-14 |
キヤノン株式会社 |
機能性組成物、それを用いた画像形成方法及び画像形成装置
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
EP2030611A1
(en)
|
2002-07-31 |
2009-03-04 |
Alza Corporation |
Injectable multimodal polymer depot compositions and uses thereof
|
ES2319400T3
(es)
|
2002-07-31 |
2009-05-07 |
Durect Corporation |
Composiciones deposito inyectables y empleo de las mismas.
|
US20060039979A1
(en)
*
|
2002-12-04 |
2006-02-23 |
Kazuhito Yamada |
Drug delivery system using subconjunctival depot
|
US20040185013A1
(en)
*
|
2003-01-30 |
2004-09-23 |
Burgio Paul A. |
Dental whitening compositions and methods
|
US20040151691A1
(en)
*
|
2003-01-30 |
2004-08-05 |
Oxman Joel D. |
Hardenable thermally responsive compositions
|
US7223826B2
(en)
*
|
2003-01-30 |
2007-05-29 |
3M Innovative Properties Company |
Amide-functional polymers, compositions, and methods
|
IL155866A0
(en)
*
|
2003-05-12 |
2003-12-23 |
Yissum Res Dev Co |
Responsive polymeric system
|
US7947295B2
(en)
|
2003-06-13 |
2011-05-24 |
Alcon, Inc. |
Ophthalmic compositions containing a synergistic combination of two polymers
|
KR20110098863A
(ko)
|
2003-06-13 |
2011-09-01 |
알콘, 인코퍼레이티드 |
시너지성의 2개의 폴리머 배합물을 포함하는 안과용 조성물
|
TWI336257B
(en)
|
2003-06-13 |
2011-01-21 |
Alcon Inc |
Ophthalmic compositions containing a synergistic combination of three polymers
|
US7914803B2
(en)
|
2003-06-13 |
2011-03-29 |
Alcon, Inc. |
Ophthalmic compositions containing a synergistic combination of three polymers
|
US20050002996A1
(en)
*
|
2003-07-02 |
2005-01-06 |
Milan Sojka |
Sustained release compositions and controlled delivery method
|
US20050059583A1
(en)
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods of providing therapeutic effects using cyclosporin components
|
DE10350248A1
(de)
*
|
2003-10-28 |
2005-06-16 |
Magnamedics Gmbh |
Thermosensitive, biokompatible Polymerträger mit veränderbarer physikalischer Struktur für die Therapie, Diagnostik und Analytik
|
GB2408937A
(en)
*
|
2003-12-09 |
2005-06-15 |
Johnson & Johnson Medical Ltd |
pH dependent medicinal compositions
|
GB0329507D0
(en)
*
|
2003-12-19 |
2004-01-28 |
Guillon Michel |
Contect lens
|
US20140162965A1
(en)
|
2004-08-25 |
2014-06-12 |
Aegis Therapeutics, Inc. |
Compositions for oral drug administration
|
US9114069B2
(en)
|
2004-08-25 |
2015-08-25 |
Aegis Therapeutics, Llc |
Antibacterial compositions for drug administration
|
US8268791B2
(en)
|
2004-08-25 |
2012-09-18 |
Aegis Therapeutics, Llc. |
Alkylglycoside compositions for drug administration
|
US9895444B2
(en)
|
2004-08-25 |
2018-02-20 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
US20060046962A1
(en)
|
2004-08-25 |
2006-03-02 |
Aegis Therapeutics Llc |
Absorption enhancers for drug administration
|
EP2457580A1
(en)
|
2004-08-25 |
2012-05-30 |
The UAB Research Foundation |
Absorption enhancers for drug administration
|
US20090047347A1
(en)
*
|
2005-07-29 |
2009-02-19 |
Aegis Therapeutics, Inc. |
Compositions for Drug Administration
|
US20060089590A1
(en)
*
|
2004-10-27 |
2006-04-27 |
John Higuchi |
Methods and devices for sustained in-vivo release of an active agent
|
US20060142234A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
US20060147485A1
(en)
*
|
2005-01-04 |
2006-07-06 |
Morten Pedersen |
Oil-in-water formulation of avermectins
|
DE102005035879A1
(de)
*
|
2005-07-30 |
2007-02-01 |
Paul Hartmann Ag |
Hydrogel
|
US20070048338A1
(en)
*
|
2005-08-26 |
2007-03-01 |
Ladd Byron S |
Compositions and methods for surface treatment in medical and surgical procedures
|
US7982066B2
(en)
|
2005-12-09 |
2011-07-19 |
Novalife, Inc. |
High protein supplement
|
US20070248630A1
(en)
*
|
2006-04-20 |
2007-10-25 |
Friden Phillip M |
Pharmaceutical formulations for iontophoretic methotrexate delivery
|
CA2652752A1
(en)
*
|
2006-04-20 |
2007-11-01 |
Transport Pharmaceuticals, Inc. |
Pharmaceutical formulations for iontophoretic drug delivery
|
WO2007130364A2
(en)
*
|
2006-05-01 |
2007-11-15 |
Riolan Technologies, Inc. |
Compositions, methods, and kits for treating dry eye
|
EP1873205A1
(en)
*
|
2006-06-12 |
2008-01-02 |
Corning Incorporated |
Thermo-responsive blends and uses thereof
|
CA2714867A1
(en)
|
2006-06-23 |
2007-12-27 |
Candace B. Pert |
Non-aggregated pharmaceutically active peptide
|
US8226949B2
(en)
|
2006-06-23 |
2012-07-24 |
Aegis Therapeutics Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
EP2056855B1
(en)
|
2006-08-31 |
2014-09-17 |
Clinuvel Pharmaceuticals Limited |
Alpha-msh derivatives for the treatment of photodermatoses
|
WO2008053810A1
(fr)
*
|
2006-10-30 |
2008-05-08 |
Mitsui Chemicals, Inc. |
Gel sensible au ph, procédé de fabrication dudit gel, et soupape sensible au ph
|
RU2340327C1
(ru)
*
|
2007-05-03 |
2008-12-10 |
Лев Давидович Раснецов |
Офтальмологический гель и способ его приготовления
|
WO2008137874A1
(en)
*
|
2007-05-04 |
2008-11-13 |
Personics Holdings Inc. |
Earguard sealing system ii: single chamber systems
|
ES2667945T3
(es)
|
2007-10-08 |
2018-05-16 |
Aurinia Pharmaceuticals Inc. |
Composiciones oftálmicas que comprenden inhibidores de calcineurina o Inhibidores de mTOR
|
WO2009062167A1
(en)
*
|
2007-11-09 |
2009-05-14 |
Personics Holdings Inc. |
Electroactive polymer systems
|
DE102007059939A1
(de)
|
2007-12-12 |
2009-06-18 |
Müller-Schulte, Detlef, Dr. |
Auflösbare, magnetische und unmagnetische Polymerträger zur Abtrennung und Wiedergewinnung von Zellen und Biosubstanzen
|
US8142870B2
(en)
*
|
2007-12-13 |
2012-03-27 |
Personics Holdings Inc. |
Energy responsive conformal device
|
US9107815B2
(en)
|
2008-02-22 |
2015-08-18 |
Allergan, Inc. |
Sustained release poloxamer containing pharmaceutical compositions
|
DK2957292T3
(en)
|
2008-03-27 |
2018-01-22 |
Clinuvel Pharmaceuticals Ltd |
VITILIGOTERAPHY
|
US20090258865A1
(en)
|
2008-03-28 |
2009-10-15 |
Hale Biopharma Ventures, Llc |
Administration of benzodiazepine compositions
|
KR101101321B1
(ko)
*
|
2008-11-03 |
2012-01-02 |
주식회사 엠씨티티 |
상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법
|
US8440631B2
(en)
|
2008-12-22 |
2013-05-14 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
AU2010259184B2
(en)
|
2009-06-09 |
2015-08-13 |
Aurinia Pharmaceuticals Inc. |
Topical drug delivery systems for ophthalmic use
|
IT1397132B1
(it)
*
|
2009-12-01 |
2013-01-04 |
Alfa Wassermann Spa |
Composizioni comprendenti antiinfiammatori non steroidei.
|
WO2011097727A1
(en)
|
2010-02-10 |
2011-08-18 |
Queen's University At Kingston |
Water with switchable ionic strength
|
ES2626151T3
(es)
|
2010-03-12 |
2017-07-24 |
Monsanto Technology Llc |
Composiciones agroquímicas en gel
|
US10154923B2
(en)
|
2010-07-15 |
2018-12-18 |
Eyenovia, Inc. |
Drop generating device
|
KR20150031340A
(ko)
|
2010-07-15 |
2015-03-23 |
코린시언 아프샐믹 인코포레이티드 |
안과용 약물 전달
|
US8684980B2
(en)
|
2010-07-15 |
2014-04-01 |
Corinthian Ophthalmic, Inc. |
Drop generating device
|
EA201390121A8
(ru)
|
2010-07-15 |
2014-02-28 |
Коринтиан Офтэлмик, Инк. |
Способ и система для выполнения дистанционного лечения и контроля
|
JP6599082B2
(ja)
*
|
2010-12-15 |
2019-10-30 |
クィーンズ ユニバーシティー アット キングストン |
半透膜を隔てた浸透圧勾配を調整するための切替可能水組成物および方法
|
GB201100820D0
(en)
|
2011-01-18 |
2011-03-02 |
Guillon Michel |
Lenses
|
EP2487185A1
(en)
|
2011-02-11 |
2012-08-15 |
Clinuvel Pharmaceuticals Limited |
Hexapeptide with improved activity in the repair of cellular DNA of dermal cells
|
RU2013142684A
(ru)
|
2011-02-22 |
2015-03-27 |
Реджентс Оф Юниверсити Оф Миннесота (Сша) |
Инкапсулированные в диоксиде кремния биоматериалы
|
US20160144038A1
(en)
|
2014-11-20 |
2016-05-26 |
Broda International, LLC |
Water-soluble supramolecular complexes
|
PT2689774T
(pt)
|
2011-03-21 |
2019-04-05 |
Broda Tech Co Ltd |
Composições de hidrogel termo-reversíveis reversivamente
|
BR112013026534A2
(pt)
*
|
2011-04-22 |
2016-12-27 |
Alcon Res Ltd |
composição oftálmica com um sistema de realce da viscosidade tendo dois diferentes agentes de realce da viscosidade
|
WO2012158964A2
(en)
|
2011-05-18 |
2012-11-22 |
Eumederis Pharmaceuticals, Inc. |
Improved peptide pharmaceuticals for osteoporosis
|
ES2917973T3
(es)
|
2011-06-14 |
2022-07-12 |
Neurelis Inc |
Administración de benzodiacepina
|
AU2012312816A1
(en)
|
2011-09-22 |
2014-04-24 |
Bausch & Lomb Incorporated |
Ophthalmic gel compositions
|
US20130101547A1
(en)
|
2011-10-19 |
2013-04-25 |
Allergan, Inc. |
Thermoresponsive compositions for dermatological use and methods thereof
|
CN104487028A
(zh)
|
2011-12-12 |
2015-04-01 |
艾诺维亚股份有限公司 |
高模量聚合物喷射器机构、喷射器装置及其使用方法
|
RU2672596C2
(ru)
*
|
2012-01-23 |
2018-11-16 |
Аллерган, Инк. |
Биологически разлагаемые или биологически разрушаемые микросферы или микрочастицы длительного высвобождения, суспендированные в затвердевающем депообразующем инъекцируемом лекарственном составе
|
JP2015526515A
(ja)
|
2012-08-31 |
2015-09-10 |
ボシュ・アンド・ロム・インコーポレイテッドBausch & Lomb Incorporated |
オメガ3脂肪酸を有する眼用組成物
|
US10005817B2
(en)
|
2012-11-20 |
2018-06-26 |
Eumederis Pharmaceuticals, Inc. |
Peptide pharmaceuticals
|
JP6525456B2
(ja)
|
2012-11-20 |
2019-06-05 |
メデリス ダイアビーティーズ,エルエルシー |
インスリン抵抗性のための改善されたペプチド製剤
|
US9534236B2
(en)
|
2013-03-08 |
2017-01-03 |
Regents Of The University Of Minnesota |
Membranes for wastewater-generated energy and gas
|
CN105764491A
(zh)
|
2013-12-09 |
2016-07-13 |
度瑞公司 |
药物活性剂复合物、聚合物复合物,以及包括其的组合物和方法
|
KR20230084337A
(ko)
|
2014-05-28 |
2023-06-12 |
메더리스 다이어비티즈, 엘엘씨 |
인슐린 저항성에 대한 개선된 펩티드 약제
|
US10035719B2
(en)
|
2014-10-15 |
2018-07-31 |
Regents Of The University Of Minnesota |
System and membrane for wastewater-generated energy and gas
|
ES2966595T3
(es)
|
2015-01-26 |
2024-04-23 |
Bausch & Lomb |
Composición de suspensión oftálmica
|
WO2016187426A1
(en)
|
2015-05-19 |
2016-11-24 |
Amorphex Therapeutics Llc |
A device that delivers a sustained low-dose of a myopia-suppressing drug
|
CA3002384C
(en)
|
2015-10-25 |
2021-02-16 |
Iview Therapeutics, Inc. |
Pharmaceutical formulations that form gel in situ
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|
KR102643190B1
(ko)
|
2017-06-10 |
2024-03-04 |
아이노비아 인코포레이티드 |
유체를 취급하기 위한, 그리고 눈에 유체를 전달하기 위한 디바이스들
|
IL311775A
(he)
|
2018-01-03 |
2024-05-01 |
Mederis Diabetes Llc |
תרופות פפטיד משופרות לטיפול ב – nash והפרעות אחרות
|
CA3121155C
(en)
*
|
2018-11-26 |
2023-09-05 |
Aiviva Biopharma, Inc. |
Pharmaceutical biodissolvable gels for drug delivery
|
EA202091615A1
(ru)
|
2018-12-21 |
2021-03-05 |
Аегис Терапьютикс, Ллс |
Интраназальные составы на основе эпинефрина и способы лечения заболевания
|
CA3167217A1
(en)
|
2020-01-13 |
2021-07-22 |
Durect Corporation |
Sustained release drug delivery systems with reduced impurities and related methods
|